ADA example [Bioanalytics]

posted by mittyri – Russia, 2019-03-18 22:20 (761 d 14:41 ago) – Posting: # 20047
Views: 3,427

Hi Helmut,

Thank you so much for the detailed answer!

» » Even in analytical methodology (say QC samples): isn't possible to handle that values (as they are) for example for the mean evaluation for some level of QC sample?

» Not sure what you mean here.

Sorry for incomplete/incorrect question.
Say ADA, getting cut-off point (IV B FDA)
What would be a best tactics for cut-off point selection?
Say the data of healthy volunteers is {100, BLOQ, BLOQ}

Edit: Guidance linked. [Helmut]

Kind regards,

Complete thread:

 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 8 (0 registered, 8 guests [including 2 identified bots]).
Forum time: Sunday 14:02 CEST (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz